Lack of Specificity of Anticyclic Citrullinated Peptide Antibodies in Advanced Human Immunodeficiency Virus Infection R du Toit, D Whitelaw, J Taljaard, L du Plessis, M Esser The Journal of Rheumatology 38 (6), 1055-1060, 2011 | 34 | 2011 |
Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa R Du Toit, PG Herbst, A Van Rensburg, LM Du Plessis, H Reuter, ... Lupus 26 (1), 38-47, 2017 | 31 | 2017 |
Fibroblastic rheumatism R du Toit, JW Schneider, DA Whitelaw JCR: Journal of Clinical Rheumatology 12 (4), 201-203, 2006 | 25 | 2006 |
Speckle tracking echocardiography in acute lupus myocarditis: comparison to conventional echocardiography R Du Toit, PG Herbst, A Van Rensburg, HW Snyman, H Reuter, ... Echo Research & Practice 4 (2), 1-19, 2017 | 21 | 2017 |
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus–a prospective cohort study R du Toit, PG Herbst, C Ackerman, AJK Pecoraro, D Claassen, HP Cyster, ... Lupus 30 (2), 256-268, 2021 | 15 | 2021 |
Clinical evolution, management and outcomes of patients with COVID-19 admitted at Tygerberg Hospital, Cape Town, South Africa: a research protocol BW Allwood, CFN Koegelenberg, E Irusen, U Lalla, R Davids, Y Chothia, ... BMJ open 10 (8), e039455, 2020 | 15 | 2020 |
Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus R du Toit, H Reuter, G Walzl, C Snyders, NN Chegou, PG Herbst, ... Rheumatology 60 (4), 2010-2021, 2021 | 14 | 2021 |
Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features R du Toit, PG Herbst, C Ackerman, AJK Pecoraro, RHR du Toit, K Hassan, ... Lupus 29 (11), 1461-1468, 2020 | 8 | 2020 |
Women in rheumatology in Africa D Dey, F Paruk, GM Mody, AA Kalla, A Adebajo, A Akpabio, MH Abu-Zaid, ... The LANCET rheumatology 4 (10), e657-e660, 2022 | 6 | 2022 |
Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice R Du Toit, S Karamchand, AF Doubell, H Reuter, PG Herbst Rheumatology 62 (2), 523-534, 2023 | 5 | 2023 |
Access to chloroquine in patients with rheumatic and musculoskeletal diseases attending rheumatology outpatient clinics during the COVID-19 pandemic SD Ntshalintshali, EM Geldenhuys, F Moosajee, WAM Musa, L Du Plessis, ... South African Medical Journal 111 (8), 720-723, 2021 | 2 | 2021 |
Oral v. pulse intravenous cyclophosphamide: A retrospective analysis of adverse events in a setting with a high burden of infectious disease E Pretorius, MR Davids, R Du Toit South African Medical Journal 105 (3), 209-214, 2015 | 2 | 2015 |
Mitral valve apparatus: echocardiographic features predicting the outcome of percutaneous mitral balloon valvotomy: cardiovascular topic R Du Toit, EAW Brice, JD Van Niekerk, AF Doubell Cardiovascular Journal of Africa 18 (3), 159-164, 2007 | 2* | 2007 |
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting JW Rood, R Du Toit SAMJ: South African Medical Journal 110 (12), 1231-1237, 2020 | 1 | 2020 |
LACK OF SPECIFICITY OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN ADVANCED HIV-INFECTION R du Toit, D Whitelaw, J Taljaard, L du Plessis, M Esser CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 29 (1), 204-204, 2011 | 1 | 2011 |
Mitral valve apparatus: echocardiographic features predicting the outcome of percutaneous mitral ballon valvotomy RD Toit, E Brice, JD Van Niekerk, AF Doubell CARDIOVASCULAR JOURNAL OF SOUTH AFRICA 18 (3), 159, 2007 | 1 | 2007 |
P98 Bone morphogenetic protein-7 as treatment in lupus nephritis: getting from bench to bedside C Smith, R du Toit, T Ollewagen Lupus Science & Medicine 11 (Suppl 1), 2024 | | 2024 |
P36 Lupus myocarditis: the role of cardiac MRI and endomyocardial biopsy as diagnostic parameters R du Toit, S Karamchand, M Rajah, J Cilliers, P Herbst, A Doubell Lupus Science & Medicine 11 (Suppl 1), 2024 | | 2024 |
Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation C Smith, R du Toit, T Ollewagen Inflammopharmacology 31 (5), 2161-2172, 2023 | | 2023 |
POS1052 RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE ACROSS CONTINENTS SL Heckert, T Maarseveen, ER Marges, A Chopra, D Vega-Morales, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 844-844, 2023 | | 2023 |